Yourgene Health (YGEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.38p
   
  • Change Today:
      0.005p
  • 52 Week High: 10.00
  • 52 Week Low: 0.31
  • Currency: UK Pounds
  • Shares Issued: 3,176.96m
  • Volume: 6,618,734
  • Market Cap: 12.07m

YGEN Overview

Yourgene Health is a leading integrated technologies and services business, enabling the delivery of genomic medicine. The group works in partnership with global leaders in DNA technology to advance diagnostic science.

1 Day Chart (07-02-2023)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -6.8% -27.4%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 0.3 0.6
Pr/Book 0.4  
Latest F'cast
Revenue 105.4% -46.6%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

YGEN Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 6.15 (9.54) (3.00)p n/a n/a n/a n/a 0.0%
31-Mar-19 8.88 3.39 0.90p 13.9 n/a n/a n/a 0.0%
31-Mar-20 16.61 (3.38) (0.40)p n/a n/a n/a n/a 0.0%
31-Mar-21 18.29 (12.00) (1.80)p n/a n/a n/a n/a 0.0%
31-Mar-22 37.56 (3.19) (0.30)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

YGEN Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-23 20.05 (5.50) (0.33)p n/a n/a n/a n/a 0.0%
31-Mar-24 22.55 (2.60) (0.08)p n/a n/a n/a n/a 0.0%
31-Mar-25 25.90 (1.60) (0.06)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

YGEN Company Announcements

Holding(s) in Company 27-Jan-2023 07:00 RNS
Directorate Change 25-Jan-2023 07:00 RNS
Director/PDMR Shareholding 18-Jan-2023 12:07 RNS

Latest YGEN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

YGEN Market Data

Currency UK Pounds
Share Price 0.38p
Change Today 0.005p
% Change -1.30 %
52 Week High 10.00
52 Week Low 0.31
Volume 6,618,734
Shares Issued 3,176.96m
Market Cap 12.07m

YGEN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.46% above the market average69.46% above the market average69.46% above the market average69.46% above the market average69.46% above the market average
79.66% above the sector average79.66% above the sector average79.66% above the sector average79.66% above the sector average79.66% above the sector average
Price Trend
99.68% below the market average99.68% below the market average99.68% below the market average99.68% below the market average99.68% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
58.54% above the market average58.54% above the market average58.54% above the market average58.54% above the market average58.54% above the market average
80.49% above the sector average80.49% above the sector average80.49% above the sector average80.49% above the sector average80.49% above the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

YGEN Dividends

No dividends found

Trades for 07-Feb-2023

Time Volume / Share Price
16:06 1,000,000 @ 0.38p
15:16 261,592 @ 0.38p
15:00 261,592 @ 0.38p
12:36 2,233 @ 0.39p
12:29 261,592 @ 0.38p

YGEN Key Personnel

CFO Barry Kenneth Hextall
CEO Lyn Rees

Top of Page